Handel nachbörslich: 3.80

Repare Therapeutics Inc (RPTX)

Repare Therapeutics Inc Aktie (RPTX) Neueste Nachrichten

Repare Therapeutics Inc (RPTX)

Repare Therapeutics Inc Aktie (RPTX) Neueste Nachrichten

Q2 2024 EPS Estimates for Repare Therapeutics Inc. (NASDAQ:RPTX) Raised by Analyst - MarketBeat

Capital One Financial Weighs in on Repare Therapeutics Inc.'s FY2028 Earnings (NASDAQ:RPTX) - MarketBeat

Repare Therapeutics Inc. (NASDAQ:RPTX) Stock Holdings Lifted by BVF Inc. IL - Defense World

Repare Therapeutics Inc. (NASDAQ:RPTX) Stock Holdings Lifted by BVF Inc. IL - MarketBeat

Repare Therapeutics Inc. Expected to Earn FY2028 Earnings of $0.35 Per Share (NASDAQ:RPTX) - Defense World

Repare Therapeutics begins NSCLC trial expansion By Investing.com - Investing.com

Repare Therapeutics begins NSCLC trial expansion By Investing.com - Investing.com UK

RPTX’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag - Yahoo Finance

Repare Therapeutics (NASDAQ:RPTX) Given Buy Rating at HC Wainwright - Defense World

Repare Therapeutics (NASDAQ:RPTX) Rating Reiterated by HC Wainwright - MarketBeat

FDA fast tracks Repare Therapeutics ovarian cancer drug By Investing.com - Investing.com Nigeria

FDA fast tracks Repare Therapeutics ovarian cancer drug - Investing.com

Repare gets FDA fast track status for ovarian cancer drug combo (NASDAQ:RPTX) - Seeking Alpha

Repare Therapeutics Inc. (NASDAQ:RPTX) Sees Large Decline in Short Interest - MarketBeat

Repare Therapeutics Inc. (NASDAQ:RPTX) Short Interest Down 23.2% in May - Defense World

Kingspan Group (OTCMKTS:KGSPY) Trading Down 2.3% - Defense World

Clearway Energy (NYSE:CWEN.A) Stock Price Up 2.8% - Defense World

Repare Therapeutics' (RPTX) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Repare Therapeutics' (RPTX) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Repare Therapeutics (NASDAQ:RPTX) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Repare Therapeutics (NASDAQ:RPTX) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024 - Manchestertimes

Ratios in Focus: Analyzing Repare Therapeutics Inc (RPTX)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex

Jump Financial LLC Acquires Shares of 39603 Repare Therapeutics Inc. (NASDAQ:RPTX) - Defense World

Stifel analysts upgrades a Buy rating for Repare Therapeutics Inc (RPTX) – Knox Daily - Knox Daily

In the Green: Repare Therapeutics Inc (RPTX) Closes at 3.40, Up/Down -2.30 from Previous Day – DWinneX - The Dwinnex

Small Cap Massively Bid Following Key Q1 Earnings Beat - The Globe and Mail

Verve Therapeutics (NASDAQ:VERV) Shares Down 3.6% - Defense World

Small Cap Massively Bid Following Key Q1 Earnings Beat - The Globe and Mail

A Guide To The Risks Of Investing In Repare Therapeutics Inc (RPTX) – Knox Daily - Knox Daily

Need To Know: Analysts Are Much More Bullish On Repare Therapeutics Inc. (NASDAQ:RPTX) - Yahoo Finance

Need To Know: Analysts Are Much More Bullish On Repare Therapeutics Inc. (NASDAQ:RPTX) - Yahoo Finance

Strength Seen in Repare Therapeutics Inc. (RPTX): Can Its 12.2% Jump Turn into More Strength? - Yahoo Movies Canada

Strength Seen in Repare Therapeutics Inc. (RPTX): Can Its 12.2% Jump Turn into More Strength? - Yahoo News UK

Repare Therapeutics First Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Repare Therapeutics First Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Repare Therapeutics First Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Small Cap Massively Bid Following Key Q1 Earnings Beat - The Globe and Mail

Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - RingCentral (NYSE - Benzinga

Repare Therapeutics Advances Oncology Trials - TipRanks.com - TipRanks

Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results - 07.05 ... - wallstreet:online

Strength Seen in Repare Therapeutics Inc. (RPTX): Can Its 12.2% Jump Turn into More Strength? - Yahoo Movies Canada

Repare Therapeutics Inc.'s (NASDAQ:RPTX) 34% Dip In Price Shows Sentiment Is Matching Revenues - Simply Wall St

Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic ... - NTB Kommunikasjon

Repare Therapeutics Appoints Steven Stein, M.D. to its Board of Directors - citybiz

Repare Therapeutics appoints new board member By Investing.com - Investing.com

Repare Therapeutics Inc.'s (NASDAQ:RPTX) market cap dropped US$21m last week; Private equity firms bore the brunt - Yahoo Finance

Private equity firms invested in Repare Therapeutics Inc. (NASDAQ:RPTX) copped the brunt of last week's US$24m market cap decline - Simply Wall St

Repare Therapeutics CEO offloads $23,776 in company stock By Investing.com - Investing.com

Ähnlich wie RPTX